Clinical trial
Evaluation of AI Medical Software-assisted LDCT Interpretation in Lung Cancer Screening and Prognosis: a Randomized Controlled Trial
NCT07280559 is registered in ClinicalTrials.gov with Taipei Veterans General Hospital, Taiwan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of AI Medical Software-assisted LDCT Interpretation in Lung Cancer Screening and Prognosis: a Randomized Controlled Trial
- Lead sponsor
- Taipei Veterans General Hospital, Taiwan
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 11, 2025
- Completion date
- December 31, 2031
- Enrollment
- 1,120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer